Phase I trial to determine the effects of food on an oral formulation of delafloxacin
Phase of Trial: Phase I
Latest Information Update: 09 Sep 2014
At a glance
- Drugs Delafloxacin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors Melinta Therapeutics
- 09 Sep 2014 Results presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 16 May 2014 Status changed from planning to completed.
- 14 Sep 2010 New trial record